Gene · 2817
Papers2,608
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
281 to 300 of 2,608
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The crosstalk between anoikis and epithelial-mesenchymal transition and their synergistic roles in predicting prognosis in colon adenocarcinoma. | Front Oncol | 2023 | 37350934 | PubTator, text mining | PubMed |
| The biological function of tumor-derived extracellular vesicles on metabolism. | Cell Commun Signal | 2023 | 37349803 | PubTator, text mining | PubMed |
| Identification of Hypoxia-Associated Signature in Colon Cancer to Assess Tumor Immune Microenvironment and Predict Prognosis Based on 14 Hypoxia-Associated Genes. | Int J Gen Med | 2023 | 37346810 | PubTator, text mining | PubMed |
| Evaluation of Semen Self-Sampling Yield Predictors and CTC Isolation by Multi-Color Flow Cytometry for Liquid Biopsy of Localized Prostate Cancer. | Cancers (Basel) | 2023 | 37345004 | PubTator, text mining | PubMed |
| Genetic alterations and molecular mechanisms underlying hereditary intrahepatic cholestasis. | Front Pharmacol | 2023 | 37324459 | PubTator, text mining | PubMed |
| Identification and validation of differentially expressed genes for targeted therapy in NSCLC using integrated bioinformatics analysis. | Front Oncol | 2023 | 37324026 | PubTator, text mining | PubMed |
| Progress on diagnostic and prognostic markers of pancreatic cancer. | Oncol Res | 2023 | 37304241 | PubTator, text mining | PubMed |
| Glypican1: A potential cancer biomarker for nanotargeted therapy. | Drug Discov Today | 2023 | 37301249 | PubTator, text mining | PubMed |
| Endothelial Glycocalyx Preservation-Impact of Nutrition and Lifestyle. | Nutrients | 2023 | 37299535 | PubTator, text mining | PubMed |
| The Importance of Detecting, Quantifying, and Characterizing Exosomes as a New Diagnostic/Prognostic Approach for Tumor Patients. | Cancers (Basel) | 2023 | 37296842 | PubTator, text mining | PubMed |
| Dual Tumor Exosome Biomarker Co-recognitions Based Nanoliquid Biopsy for the Accurate Early Diagnosis of Pancreatic Cancer. | ACS Nano | 2023 | 37288703 | PubTator, text mining | PubMed |
| Comprehensive analysis of 33 human cancers reveals clinical implications and immunotherapeutic value of the solute carrier family 35 member A2. | Front Immunol | 2023 | 37275857 | PubTator, text mining | PubMed |
| Large-scale heparin-based bind-and-elute chromatography identifies two biologically distinct populations of extracellular vesicles. | J Extracell Vesicles | 2023 | 37272197 | PubTator, text mining | PubMed |
| The acyltransferase Gpc1 is both a target and an effector of the unfolded protein response in Saccharomyces cerevisiae. | J Biol Chem | 2023 | 37269946 | PubTator, text mining | PubMed |
| The human neurosecretome: extracellular vesicles and particles (EVPs) of the brain for intercellular communication, therapy, and liquid-biopsy applications. | Front Mol Biosci | 2023 | 37266331 | PubTator, text mining | PubMed |
| Recombinant Endostatin as a Potential Radiosensitizer in the Treatment of Non-Small Cell Lung Cancer. | Pharmaceuticals (Basel) | 2023 | 37259367 | PubTator, text mining | PubMed |
| Alveolar epithelial cells are competent producers of interstitial extracellular matrix with disease relevant plasticity in a human in vitro 3D model. | Sci Rep | 2023 | 37258541 | PubTator, text mining | PubMed |
| Association analysis and functional follow-up identified common variants of JAG1 accounting for risk to biliary atresia. | Front Genet | 2023 | 37255715 | PubTator, text mining | PubMed |
| Rethinking Antigen Source: Cancer Vaccines Based on Whole Tumor Cell/tissue Lysate or Whole Tumor Cell. | Adv Sci (Weinh) | 2023 | 37254712 | PubTator, text mining | PubMed |
| Nano-particulate Toll-like Receptor 9 Agonist Potentiates the Antitumor Activity of Anti-Glypican-1 Antibody. | Anticancer Res | 2023 | 37247902 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2817/papers?page=15